Driehaus Capital Management LLC Abiomed Inc Transaction History

Driehaus Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $1.69 Million - $2.67 Million	-6,021 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $1.54 Million - $1.95 Million	-4,332 Reduced 41.84%	6,021 $2.71 Million
Q2 2018 Aug 14, 2018	BUY	$278.07 - $446.21 $1.2 Million - $1.92 Million	4,299 Added 71.01%	10,353 $4.24 Million
Q1 2018 May 15, 2018	BUY	$192.49 - $295.85 $7,892 - $12,129	41 Added 0.68%	6,054 $1.76 Million
Q4 2017 Feb 14, 2018	BUY	$168.78 - $199.74 $197,472 - $233,695	1,170 Added 24.16%	6,013 $1.13 Million
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $704,123 - $816,529	4,843	4,843 $817,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.